25 авг. 2023 г. · The aim of this ESC guideline is to help health professionals manage people with heart failure (HF) according to the best available evidence.

The guidelines are unanimous that intravenous iron should be used in patients with HFrEF and iron deficiency (defined as ferritin < 100 ng/mL, or transferrin ...

25 авг. 2023 г. · This 2023 Focused Update addresses changes in recommendations for the treatment of HF because of this new evidence. New evidence was considered ...

All individuals with a diagnosis of HFpEF should be treated with an SGLT2i, with the goal of reducing cardiovascular death/HF hospitalization and improving ...

Take Home Point: Class 1 recommended medical therapies for HFrEF have very high economic value (low cost).

The task force decided to provide a focused update of the 2021 guidelines, which includes a few important novel recommendations that are outlined below.

This guideline gives recommendations on CV risk stratification as well as on screening, diagnosis, and treatment of CVD in patients with ...

1 окт. 2023 г. · 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Summary of the new recommendations in the 2023 update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. ACE-I, ...

1 апр. 2022 г. · The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure. Vol 145, No 18 · Correction to · Doi: 10.